1. Home
  2. LMAT vs TARS Comparison

LMAT vs TARS Comparison

Compare LMAT & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • TARS
  • Stock Information
  • Founded
  • LMAT 1983
  • TARS 2016
  • Country
  • LMAT United States
  • TARS United States
  • Employees
  • LMAT N/A
  • TARS N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • LMAT Health Care
  • TARS Health Care
  • Exchange
  • LMAT Nasdaq
  • TARS Nasdaq
  • Market Cap
  • LMAT 2.1B
  • TARS 2.1B
  • IPO Year
  • LMAT 2006
  • TARS 2020
  • Fundamental
  • Price
  • LMAT $100.15
  • TARS $46.74
  • Analyst Decision
  • LMAT Buy
  • TARS Strong Buy
  • Analyst Count
  • LMAT 7
  • TARS 5
  • Target Price
  • LMAT $92.83
  • TARS $54.20
  • AVG Volume (30 Days)
  • LMAT 152.8K
  • TARS 709.0K
  • Earning Date
  • LMAT 02-25-2025
  • TARS 02-25-2025
  • Dividend Yield
  • LMAT 0.64%
  • TARS N/A
  • EPS Growth
  • LMAT 49.21
  • TARS N/A
  • EPS
  • LMAT 1.82
  • TARS N/A
  • Revenue
  • LMAT $213,029,000.00
  • TARS $129,621,000.00
  • Revenue This Year
  • LMAT $16.04
  • TARS $917.88
  • Revenue Next Year
  • LMAT $9.62
  • TARS $78.70
  • P/E Ratio
  • LMAT $55.23
  • TARS N/A
  • Revenue Growth
  • LMAT 14.81
  • TARS 801.96
  • 52 Week Low
  • LMAT $56.04
  • TARS $20.08
  • 52 Week High
  • LMAT $109.58
  • TARS $57.14
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 64.00
  • TARS 37.90
  • Support Level
  • LMAT $96.80
  • TARS $43.61
  • Resistance Level
  • LMAT $100.85
  • TARS $57.00
  • Average True Range (ATR)
  • LMAT 2.31
  • TARS 2.72
  • MACD
  • LMAT 1.08
  • TARS -1.16
  • Stochastic Oscillator
  • LMAT 94.54
  • TARS 23.13

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: